

| Particulars (in ₹ Cr.) | FY 2021 | FY 2020 |
|---|---|---|
| Total Revenue | 507.99 | 544.01 |
| Total Expenses | 318.03 | 349.88 |
| Profit Before Tax | 184.66 | 194.13 |
| Profit After Tax | 135.79 | 144.96 |
| Operating Profit After Depreciation | 195.27 | 201.50 |
| Particulars (in ₹ Cr.) | FY 2021 | FY 2020 |
|---|---|---|
| Fixed Assets | 138.92 | 107.16 |
| Total Non Current Assets | 146.24 | 126.59 |
| Total Current Assets | 390.03 | 248.80 |
| Total Assets | 536.27 | 375.39 |
| Total Shareholder's Fund | 339.82 | 201.42 |
| Particulars (in ₹ Cr.) | FY 2021 | FY 2020 |
|---|---|---|
| Net Cash From Operating Activities | 129.28 | 122.73 |
| Net Cash Used In Investing Activities | -50.73 | -45.24 |
| Net Cash Used In Financing Activities | -27.50 | -72.50 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 1,076.24 | 740.46 | 744.94 | 702.88 | 507.71 |
| Total Expenses | 670.14 | 510.62 | 528.33 | 459.65 | 317.23 |
| Profit Before Tax | 406.10 | 220.09 | 216.61 | 243.23 | 190.49 |
| Profit After Tax | 305.20 | 163.75 | 160.03 | 181.59 | 141.62 |
| Operating Profit After Depreciation | 406.20 | 230 | 217.97 | 246.53 | 195.79 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 300.57 | 171.94 | 151.04 | 156.48 | 138.92 |
| Total Non Current Assets | 411.58 | 353.21 | 197.02 | 165.03 | 144.44 |
| Total Current Assets | 1,005.95 | 705.64 | 665.05 | 548.35 | 389.12 |
| Total Assets | 1,417.53 | 1,058.85 | 862.07 | 713.38 | 533.56 |
| Total Shareholder's Fund | 1,133.11 | 845.22 | 681.49 | 521.54 | 339.82 |
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 45.76 | 241.26 | 141.56 | 146.42 | 136.78 |
| Net Cash Used In Investing Activities | -35.18 | -263.76 | -147.25 | -76.03 | -60.98 |
| Net Cash Used In Financing Activities | -18.56 | -1.99 | -4.24 | -56.15 | -20.55 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 234.67 | 192.41 | 165.48 | 354.76 | 340.45 |
| Total Expenses | 163.40 | 145.53 | 110.53 | 233.76 | 200.47 |
| Profit Before Tax | 87.15 | 53.77 | 68.72 | 122.86 | 147.23 |
| Profit After Tax | 64.34 | 40.17 | 52.14 | 91.17 | 110.10 |
| Operating Profit after Depreciation | 94.19 | 60.09 | 79.22 | 129.25 | 152.21 |
₹1.2/Share
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
On 17 June 2026
29 May 2026, 12:33 pm
Blue Jet Healthcare surged 6.26% to Rs 511.55 after the company reported strong sequential improvement in quarterly earnings.
26 May 2026, 10:41 am
Of Rs 1.2 per share
25 May 2026, 06:43 pm
At meeting held on 25 May 2026
25 May 2026, 02:34 pm
On 25 May 2026
20 May 2026, 05:45 pm

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Get started with us today and
start building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.

Congratulations,
Your Digital savings bank account opening journey is complete.